NCT07407517 2026-02-12
POLARIS
Fudan University
Phase 3 Not yet recruiting
Clinical Trials
3 trialsNCT07178730 2025-09-17
ADAPT-TN-IV
West German Study Group
Phase 3 Not yet recruiting
NCT04301739 2020-03-12
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)
Shanghai Henlius Biotech
Phase 3 Not yet recruiting